News from eurocine vaccines A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

08 Aug, 2018, 08:09 BST Eurocine Vaccines´ Nasal Influenza Vaccine Candidate Immunose™ FLU Showed Good Safety in Older Adults

Eurocine Vaccines today announced good safety and tolerability in older adults, in the second clinical phase I/II study including their quadrivalent...


18 May, 2018, 07:22 BST Eurocine Vaccines has Completed Dosing of its Quadrivalent Influenza Vaccine Candidate, Immunose™ FLU, in the Second Clinical Study

This week, dosing was completed according to plan in the second clinical study with Immunose™ FLU, developed with the aim to become a modern and...


07 Feb, 2018, 15:45 GMT Eurocine Vaccines Takes Advantage of Yet Another Influenza Season, Launching its Second Clinical Study on Immunose™ FLU

Eurocine Vaccines initiates a phase I/II clinical study in older adults with its quadrivalent nasal influenza vaccine candidate Immunose™ FLU. The...


11 Jan, 2018, 15:10 GMT Eurocine Vaccines Obtains Authorization to Conduct the Next Study with Immunose™ FLU

Eurocine Vaccines today announced that the company has received authorization to conduct a phase I/II clinical study on the quadrivalent influenza...


07 Apr, 2017, 10:51 BST Eurocine Vaccines Strengthens the Organization for Further Development

Eurocine Vaccines strengthens the organization with necessary competence, not only to prepare for further development of its first product, the nasal ...